Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Delcath Systems stock | $16.22

Own Delcath Systems stock in just a few minutes.

Fact checked

Delcath Systems, Inc is a medical devices business based in the US. Delcath Systems shares (DCTH) are listed on the NASDAQ and all prices are listed in US Dollars. Delcath Systems employs 33 staff and has a trailing 12-month revenue of around USD$1.7 million.

How to buy shares in Delcath Systems

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Delcath Systems. Find the stock by name or ticker symbol: DCTH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Delcath Systems reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$16.22, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Delcath Systems, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Delcath Systems. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Delcath Systems share price

Use our graph to track the performance of DCTH stocks over time.

Delcath Systems shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$16.22
52-week rangeUSD$6.06 - USD$24
50-day moving average USD$15.0934
200-day moving average USD$11.8425
Wall St. target priceUSD$19.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.838

Buy Delcath Systems shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Delcath Systems stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Delcath Systems price performance over time

Historical closes compared with the close of $16.22 from 2020-12-09

1 week (2021-01-07) -11.46%
1 month (2020-12-17) -0.43%
3 months (2020-10-15) 40.43%
6 months (2020-07-15) 77.27%
1 year (2020-01-15) 8.13%
2 years (2019-01-15) 5,918.55%
3 years (2018-01-13) N/A
5 years (2016-01-15) 3,504.44%

Delcath Systems financials

Revenue TTM USD$1.7 million
Gross profit TTM USD$861,000
Return on assets TTM -66.49%
Return on equity TTM 0%
Profit margin -279.89%
Book value $0.812
Market capitalisation USD$98.9 million

TTM: trailing 12 months

Shorting Delcath Systems shares

There are currently 181,313 Delcath Systems shares held short by investors – that's known as Delcath Systems's "short interest". This figure is 19.8% up from 151,336 last month.

There are a few different ways that this level of interest in shorting Delcath Systems shares can be evaluated.

Delcath Systems's "short interest ratio" (SIR)

Delcath Systems's "short interest ratio" (SIR) is the quantity of Delcath Systems shares currently shorted divided by the average quantity of Delcath Systems shares traded daily (recently around 166342.20183486). Delcath Systems's SIR currently stands at 1.09. In other words for every 100,000 Delcath Systems shares traded daily on the market, roughly 1090 shares are currently held short.

However Delcath Systems's short interest can also be evaluated against the total number of Delcath Systems shares, or, against the total number of tradable Delcath Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Delcath Systems's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Delcath Systems shares in existence, roughly 30 shares are currently held short) or 0.0351% of the tradable shares (for every 100,000 tradable Delcath Systems shares, roughly 35 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Delcath Systems.

Find out more about how you can short Delcath Systems stock.

Delcath Systems share dividends

We're not expecting Delcath Systems to pay a dividend over the next 12 months.

Have Delcath Systems's shares ever split?

Delcath Systems's shares were split on a 1:700 basis on 24 December 2019. So if you had owned 700 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Delcath Systems shares – just the quantity. However, indirectly, the new 69900% higher share price could have impacted the market appetite for Delcath Systems shares which in turn could have impacted Delcath Systems's share price.

Delcath Systems share price volatility

Over the last 12 months, Delcath Systems's shares have ranged in value from as little as $6.06 up to $24. A popular way to gauge a stock's volatility is its "beta".

DCTH.US volatility(beta: 0.79)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Delcath Systems's is 0.7932. This would suggest that Delcath Systems's shares are less volatile than average (for this exchange).

Delcath Systems overview

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company's lead product candidate is the melphalan hydrochloride for injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. Its Phase III clinical trial products include FOCUS Trial for the patients with hepatic dominant ocular melanoma; and ALIGN Trial for intrahepatic cholangiocarcinoma. The company also offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site